J. Estrada

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

William T. Hu, M. Diamond, J. Crowe, 2020, Nature Immunology.

An Evaluation of the Safety and Immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled study

M. Lin, C. Chen, H. Cheng, 2022, medRxiv.

Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation

W. Chen, I. Sanz, S. Kyu, 2020, medRxiv.

Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes

William T. Hu, I. Sanz, S. Kyu, 2020 .